These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

603 related articles for article (PubMed ID: 33991233)

  • 21. Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction.
    Yu Z; Shi M; Stewart T; Fernagut PO; Huang Y; Tian C; Dehay B; Atik A; Yang D; De Giorgi F; Ichas F; Canron MH; Ceravolo R; Frosini D; Kim HJ; Feng T; Meissner WG; Zhang J
    Brain; 2020 Jun; 143(6):1780-1797. PubMed ID: 32428221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma biomarkers of decreased vesicular storage distinguish Parkinson disease with orthostatic hypotension from the parkinsonian form of multiple system atrophy.
    Goldstein DS; Kopin IJ; Sharabi Y; Holmes C
    Clin Auton Res; 2015 Feb; 25(1):61-7. PubMed ID: 25638582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
    Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
    Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phosphorylated α-synuclein in skin Schwann cells: a new biomarker for multiple system atrophy.
    Donadio V; Incensi A; Rizzo G; Westermark GT; Devigili G; De Micco R; Tessitore A; Nyholm D; Parisini S; Nyman D; Tedeschi G; Eleopra R; Ingelsson M; Liguori R
    Brain; 2023 Mar; 146(3):1065-1074. PubMed ID: 35552610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lysosomal response in relation to α-synuclein pathology differs between Parkinson's disease and multiple system atrophy.
    Puska G; Lutz MI; Molnar K; Regelsberger G; Ricken G; Pirker W; Laszlo L; Kovacs GG
    Neurobiol Dis; 2018 Jun; 114():140-152. PubMed ID: 29505813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
    Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
    Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The plasma alpha-synuclein levels in patients with Parkinson's disease and multiple system atrophy.
    Lee PH; Lee G; Park HJ; Bang OY; Joo IS; Huh K
    J Neural Transm (Vienna); 2006 Oct; 113(10):1435-9. PubMed ID: 16465458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skin Biopsy May Help to Distinguish Multiple System Atrophy-Parkinsonism from Parkinson's Disease With Orthostatic Hypotension.
    Donadio V; Incensi A; Rizzo G; De Micco R; Tessitore A; Devigili G; Del Sorbo F; Bonvegna S; Infante R; Magnani M; Zenesini C; Vignatelli L; Cilia R; Eleopra R; Tedeschi G; Liguori R
    Mov Disord; 2020 Sep; 35(9):1649-1657. PubMed ID: 32557839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis.
    Wang P; Lan G; Xu B; Yu Z; Tian C; Lei X; Meissner WG; Feng T; Yang Y; Zhang J
    Transl Neurodegener; 2023 Aug; 12(1):40. PubMed ID: 37620916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different neurotoxicity and seeding activity between α-synuclein oligomers formed in plasma of patients with Parkinson's disease and multiple system atrophy.
    Luo H; Yu X; Li P; Hu J; Li W; Li X; Chen M; Yu S
    Neuroscience; 2024 Oct; 557():1-11. PubMed ID: 39127345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of α-Synuclein in L1CAM-Immunocaptured Exosomes as a Biomarker for the Stratification of Parkinsonian Syndromes.
    Jiang C; Hopfner F; Berg D; Hu MT; Pilotto A; Borroni B; Davis JJ; Tofaris GK
    Mov Disord; 2021 Nov; 36(11):2663-2669. PubMed ID: 33826157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease and multiple system atrophy have distinct α-synuclein seed characteristics.
    Yamasaki TR; Holmes BB; Furman JL; Dhavale DD; Su BW; Song ES; Cairns NJ; Kotzbauer PT; Diamond MI
    J Biol Chem; 2019 Jan; 294(3):1045-1058. PubMed ID: 30478174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propagative α-synuclein seeds as serum biomarkers for synucleinopathies.
    Okuzumi A; Hatano T; Matsumoto G; Nojiri S; Ueno SI; Imamichi-Tatano Y; Kimura H; Kakuta S; Kondo A; Fukuhara T; Li Y; Funayama M; Saiki S; Taniguchi D; Tsunemi T; McIntyre D; Gérardy JJ; Mittelbronn M; Kruger R; Uchiyama Y; Nukina N; Hattori N
    Nat Med; 2023 Jun; 29(6):1448-1455. PubMed ID: 37248302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies.
    Gibbons CH; Levine T; Adler C; Bellaire B; Wang N; Stohl J; Agarwal P; Aldridge GM; Barboi A; Evidente VGH; Galasko D; Geschwind MD; Gonzalez-Duarte A; Gil R; Gudesblatt M; Isaacson SH; Kaufmann H; Khemani P; Kumar R; Lamotte G; Liu AJ; McFarland NR; Miglis M; Reynolds A; Sahagian GA; Saint-Hillaire MH; Schwartzbard JB; Singer W; Soileau MJ; Vernino S; Yerstein O; Freeman R
    JAMA; 2024 Apr; 331(15):1298-1306. PubMed ID: 38506839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease.
    Gibbons C; Wang N; Rajan S; Kern D; Palma JA; Kaufmann H; Freeman R
    Neurology; 2023 Apr; 100(15):e1529-e1539. PubMed ID: 36657992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone response to arginine test distinguishes multiple system atrophy from Parkinson's disease and idiopathic late-onset cerebellar ataxia.
    Pellecchia MT; Pivonello R; Salvatore E; Faggiano A; Barone P; De Michele G; Lombardi G; Colao A; Filla A
    Clin Endocrinol (Oxf); 2005 Apr; 62(4):428-33. PubMed ID: 15807873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long Noncoding RNA POU3F3 and α-Synuclein in Plasma L1CAM Exosomes Combined with β-Glucocerebrosidase Activity: Potential Predictors of Parkinson's Disease.
    Zou J; Guo Y; Wei L; Yu F; Yu B; Xu A
    Neurotherapeutics; 2020 Jul; 17(3):1104-1119. PubMed ID: 32236821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
    Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced alpha-synuclein in cerebrospinal fluid in synucleinopathies: evidence from a meta-analysis.
    Sako W; Murakami N; Izumi Y; Kaji R
    Mov Disord; 2014 Nov; 29(13):1599-605. PubMed ID: 25258345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoimmune antibody decline in Parkinson's disease and Multiple System Atrophy; a step towards immunotherapeutic strategies.
    Brudek T; Winge K; Folke J; Christensen S; Fog K; Pakkenberg B; Pedersen LØ
    Mol Neurodegener; 2017 Jun; 12(1):44. PubMed ID: 28592329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.